Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Related Citations for PubMed (Select 23192867)

1.

Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies.

Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, Hooper DC, Faber M.

J Virol. 2013 Feb;87(3):1834-41. doi: 10.1128/JVI.02589-12. Epub 2012 Nov 28.

2.
3.

Investigating the role for IL-21 in rabies virus vaccine-induced immunity.

Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP.

PLoS Negl Trop Dis. 2013;7(3):e2129. doi: 10.1371/journal.pntd.0002129. Epub 2013 Mar 14.

4.

ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.

Norton JE Jr, Lytle AG, Shen S, Tzvetkov EP, Dorfmeier CL, McGettigan JP.

PLoS One. 2014 Jan 29;9(1):e87098. doi: 10.1371/journal.pone.0087098. eCollection 2014.

5.

Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.

Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF.

J Virol. 2011 Feb;85(4):1634-44. doi: 10.1128/JVI.01552-10. Epub 2010 Nov 24.

6.

B cell infection and activation by rabies virus-based vaccines.

Lytle AG, Norton JE Jr, Dorfmeier CL, Shen S, McGettigan JP.

J Virol. 2013 Aug;87(16):9097-110. doi: 10.1128/JVI.00800-13. Epub 2013 Jun 12.

7.

Reinvestigating the role of IgM in rabies virus postexposure vaccination.

Dorfmeier CL, Shen S, Tzvetkov EP, McGettigan JP.

J Virol. 2013 Aug;87(16):9217-22. doi: 10.1128/JVI.00995-13. Epub 2013 Jun 12.

8.

Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.

Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ.

J Virol. 2011 Oct;85(20):10605-16. doi: 10.1128/JVI.00558-11. Epub 2011 Aug 17.

9.

Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.

Zhao L, Toriumi H, Wang H, Kuang Y, Guo X, Morimoto K, Fu ZF.

J Virol. 2010 Sep;84(18):9642-8. doi: 10.1128/JVI.00326-10. Epub 2010 Jun 30.

10.

Adeno-associated viruses serotype 2-mediated RNA interference efficiently inhibits rabies virus replication in vitro and in vivo.

Wu HX, Wang HL, Guo XF, Yang YJ, Ma JZ, Wang TC, Gao YW, Zhao YK, Yang ST, Xia XZ.

J Vet Med Sci. 2013 Oct;75(10):1355-61. Epub 2013 Jul 14.

11.

A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.

Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ.

J Virol. 2013 Feb;87(3):1618-30. doi: 10.1128/JVI.02470-12. Epub 2012 Nov 21.

12.

Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations.

Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF.

PLoS One. 2013 May 20;8(5):e63384. doi: 10.1371/journal.pone.0063384. Print 2013.

13.

Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.

Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z.

Vaccine. 2012 Jul 20;30(34):5067-72. doi: 10.1016/j.vaccine.2012.06.001. Epub 2012 Jun 12.

PMID:
22698451
14.

Recombinant rabies virus expressing IFN╬▒1 enhanced immune responses resulting in its attenuation and stronger immunogenicity.

Wang Y, Tian Q, Xu X, Yang X, Luo J, Mo W, Peng J, Niu X, Luo Y, Guo X.

Virology. 2014 Nov;468-470:621-30. doi: 10.1016/j.virol.2014.09.010. Epub 2014 Oct 11.

PMID:
25310498
15.

Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.

Wu X, Franka R, Henderson H, Rupprecht CE.

Vaccine. 2011 Jun 6;29(25):4195-201. doi: 10.1016/j.vaccine.2011.03.104. Epub 2011 Apr 21.

PMID:
21514343
16.

Limited brain metabolism changes differentiate between the progression and clearance of rabies virus.

Schutsky K, Portocarrero C, Hooper DC, Dietzschold B, Faber M.

PLoS One. 2014 Apr 24;9(4):e87180. doi: 10.1371/journal.pone.0087180. eCollection 2014.

17.

A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.

Liu X, Yang Y, Sun Z, Chen J, Ai J, Dun C, Fu ZF, Niu X, Guo X.

PLoS One. 2014 Feb 3;9(2):e87105. doi: 10.1371/journal.pone.0087105. eCollection 2014.

18.

Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus.

Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF.

PLoS One. 2011;6(9):e25414. doi: 10.1371/journal.pone.0025414. Epub 2011 Sep 28.

19.

Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.

Vaccine. 2008 Nov 25;26(50):6405-14. doi: 10.1016/j.vaccine.2008.08.069. Epub 2008 Sep 18.

20.

Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.

Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP.

J Virol. 2012 Nov;86(21):11533-40. doi: 10.1128/JVI.00615-12. Epub 2012 Aug 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk